Literature DB >> 30571424

National Institutes of Health Stroke Scale Zero Strokes.

Elissavet Eskioglou1, Mitra Huchmandzadeh Millotte2, Michael Amiguet3, Patrik Michel1.   

Abstract

Background and Purpose- We aimed to characterize acute ischemic stroke patients who have an immeasurable deficit on the admission National Institutes of Health Stroke Scale (NIHSS), and to evaluate their long-term outcome. Methods- We retrospectively compared all acute ischemic stroke patients with an admission NIHSS of 0 in the Acute Stroke Registry and Analysis of Lausanne from 2003 to 2013 with all other acute ischemic stroke patients. We compared demographics, clinical, radiological, and laboratory findings. Outcome was considered favorable at 3 months if the modified Rankin Scale score corrected for prestroke disability was ≤1. Stroke recurrences >12 months were also assessed. Results- Comparing 108 NIHSS zero (NIHSS=0) patients with the 2889 other strokes by multivariate analysis, NIHSS=0 had lower prestroke disability, longer onset-to-hospital delays and more lacunar and infratentorial strokes. NIHSS=0 patients were less likely to have early ischemic changes on acute computed tomography, had less arterial pathology and lower creatinine levels. They were more likely to have favorable modified Rankin Scale score after correction for prestroke modified Rankin Scale score (zero versus others: 83.2% versus 44.6%) and less likely to die (3.9% versus 13.3%) at 12 months. Stroke and transient ischemic attack recurrence rates were similar (11% versus 11.4%), however. Conclusions- Patients with NIHSS=0 strokes are characterized by lacunar and infrantentorial strokes, normal acute computed tomography, and less arterial pathology. However, a significant proportion face recurrent ischemic events and persistent handicap at 12 months. Therefore, NIHSS=0 stroke patients require aggressive secondary prevention and adequate follow-up.

Entities:  

Keywords:  blood pressure; cerebrovascular diseases; prognosis; risk factors; stroke

Mesh:

Year:  2018        PMID: 30571424     DOI: 10.1161/STROKEAHA.118.022517

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  6 in total

1.  Cerebellar infarction presenting with isolated positional vertigo: differentiating factors for benign paroxysmal positional vertigo.

Authors:  Jae-Myung Kim; Seung-Han Lee; Soo Hyun Cho; Kyung Wook Kang; Kang-Ho Choi; Tai-Seung Nam; Joon-Tae Kim; Seong-Min Choi; Man-Seok Park; Byeong C Kim; Myeong-Kyu Kim
Journal:  Neurol Sci       Date:  2020-07-28       Impact factor: 3.307

2.  The Role of Establishing Neurosurgical Specialist Nurse Working Group in the Recovery and Prevention of Negative Psychological Emotion after Meningioma Surgery.

Authors:  Zhen Luo; Qiaoyu Yang; Min Tang; Chaofeng Fan
Journal:  Contrast Media Mol Imaging       Date:  2022-06-27       Impact factor: 3.009

3.  Study on the Effects of Optimized Emergency Nursing Combined with Mild Hypothermia Nursing on Neurological Prognosis, Hemodynamics, and Cytokines in Patients with Cardiac Arrest.

Authors:  Xiaoxia Wang; Chengxia Wu
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-26       Impact factor: 2.650

4.  Intravenous thrombolysis with alteplase in the treatment of acute cerebral infarction.

Authors:  Lilin Gao; Shaojie Zhang; Xuewen Wo; Xiangpeng Shen; Qiangyuan Tian; Guoqing Wang
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 1.088

5.  Effective Analysis of Multichannel Functional Electrical Stimulation plus Early Rehabilitation Training for Hemiplegic Patients after Stroke.

Authors:  Yan Hou; Li Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-07       Impact factor: 2.650

6.  Analysis of Clinical Effects of Comprehensive Nursing Based on Enhanced Recovery after Surgery in Patients with Embolization for Intracranial Aneurysms.

Authors:  Jing Liu; Kunxian Zhang; Bei Wang; Qin Hu; Qing Zhang; Lei Wan; Xianpu Wang; Wenping Xiong
Journal:  Comput Math Methods Med       Date:  2022-07-08       Impact factor: 2.809

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.